Nerve stimulation for cluster headaches

March 25, 2010

Occipital nerve stimulation has been under investigation for the treatment of difficult to treat migraine headaches for the past several years with promising results.  A recent study at the Mayo Clinic in Scottsdale, AZ suggests that this treatment may also help relieve chronic cluster headaches.  It is less surprising that the occipital nerve stimulation works for cluster headaches than for migraines.  It is not unusual for cluster headache patients to complain of pain not only in the eye, but also in the back of the head on the same side.  Also, occipital nerve block with steroids has been shown to abort an episode of episodic cluster headaches and is widely used by headache specialists.  In chronic cluster patients this block may provide temporary relief and these patients may be good candidates for an occipital nerve stimulation.  The stimulator is usually implanted by a neurosurgeon in an out-patient procedure.  The wire electrode and the battery are embedded under the skin.  Another miniature stimulator which has been in development contains both the electrode and the battery in a very small capsule-size device.  This miniature stimulator is much easier to implant and it is less bothersome.

Written by
Alexander Mauskop, MD
Continue reading
June 7, 2026
News
A new edition of my migraine book and an upcoming conversation with Dr. Sanjay Gupta
An overview of why I updated The End of Migraines: 150 Ways to Stop Your Pain for a 3rd edition, what has changed in migraine treatment, and how a more structured, realistic approach can help people who feel they’ve “tried everything.”
Read article
June 4, 2026
Research
A New Study of Meat Intake, Genetics, and Brain Health
A newly published Swedish study suggests that the relationship between diet and brain aging may be more genetically specific than previously understood. Researchers followed over 2,000 older adults for up to 15 years and found that higher meat consumption was associated with slower cognitive decline and lower dementia risk, but only in those carrying the APOE E4 genetic variant, the most common hereditary risk factor for Alzheimer's disease. This may be relevant for people with headaches.
Read article
June 3, 2026
News
Keynote address at the 22nd Annual Neuroscience Zappulla Research Day
I was honored to be delivering the keynote address at the 22nd Annual Neuroscience Zappulla Research Day on Wednesday, June 3, at the Hackensack Meridian Neuroscience Institute, JFK University Medical Center in Edison, NJ.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe